Medicare billing address
CMS Medicare provider billing file
810 Jasonway Ave Ste AColumbus, OH 43214
CMS public data · NPI 1043355688
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Erin M Bertino, MD
Specialty
Credential
MD
NPI
1043355688
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Erin M Bertino, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
810 Jasonway Ave Ste ACMS Doctors & Clinicians file
3595 Olentangy River RdCMS Doctors & Clinicians file
810 Jasonway AveIn the 2024 CMS provider billing file, this NPI had 244 Medicare beneficiaries and 36,332 total services. The average beneficiary age was 74, and the average HCC risk score was 2.
Total Medicare allowed amount
$896,603.51
Total Medicare payment amount
$714,583.68
Medicare beneficiaries
244
Total services
36,332
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hypertension
75%
CMS beneficiary-panel share
Hyperlipidemia
73%
CMS beneficiary-panel share
Chronic kidney disease
32%
CMS beneficiary-panel share
Diabetes
32%
CMS beneficiary-panel share
Ischemic heart disease
32%
CMS beneficiary-panel share
Anxiety
31%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, dexamethasone sodium phosphate, 1 mg | 716 | $0.11 |
| Injection, palonosetron hcl, 25 mcg | 320 | $0.77 |
| Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg | 216 | $146.06 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 191 | $15.66 |
| Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more | 115 | $168.29 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 103 | $121.05 |
| Administration of chemotherapy into vein, 1 hour or less | 80 | $112.72 |
| Injection of additional new drug or substance into vein | 75 | $13.86 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 48 | $24.84 |
| Injection of drug or substance under skin or into muscle | 45 | $13.35 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1043355688. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Anastrozole | Anastrozole | 92 | 177 | $1,100.43 |
| 2 | Letrozole | Letrozole | 49 | 89 | $485.88 |
| 3 | Dexamethasone | Dexamethasone | 41 | 41 | $474.11 |
| 4 | Acyclovir | Acyclovir | 37 | 55 | $360.43 |
| 5 | Eliquis | Apixaban | 34 | 34 | $19,682.15 |
| 6 | Prednisone | Prednisone | 30 | 31.2 | $170.60 |
| 7 | Furosemide | Furosemide | 28 | 39.8 | $42.66 |
| 8 | Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 25 | 26.8 | $63.23 |
| 9 | Prochlorperazine Maleate | Prochlorperazine Maleate | 20 | 20 | $170.11 |
| 10 | Alendronate Sodium | Alendronate Sodium | 16 | 39.4 | $30.20 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Northeastern Ohio University College Of Medicine
Graduation year
2004
Group/practice field
Ohiohealth Corporation
Telehealth reported
Yes
Secondary specialty fields reported by CMS: Hematology.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.